We used the stage II sub-framework and the regressor block of the CNNRF to conduct a correlation analysis between the lesion areas detected by the framework and five clinical indicators (white blood cell count, neutrophil percentage, lymphocyte percentage, procalcitonin, C-reactive protein) of COVID-19 using the CADS.